Comparative clinical study of pathyadi churn and erand tail in Aamvat (joint related disorder)
Phase 1
- Conditions
- Health Condition 1: M057- Rheumatoid arthritis with rheumatoid factor without organ or systems involvement
- Registration Number
- CTRI/2024/03/063710
- Lead Sponsor
- Department of Kayachikitsa Faculty of Ayurveda
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients willing to participate for this trial. Diagnosed cases of Amavata based on symptoms and signs described in Madava Nidana & ACR-EULAR 2010. Sero positive &Sero negative both cases are included.
Exclusion Criteria
Not willing patients.
Patients with short history of less than a year. Patients having severe deformities.
Patients of Gouty Arthritis, Septic Arthritis, Osteoarthritis, Ankylosing Spondylitis.
HIV, Tuberculosis, Hypertension, D.M., & other systemic problems.
? Pregnant & lactating women
? Patients with major complications are like pleural effusion, ascites also excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A) Pain <br/ ><br>B) TENDERNESS <br/ ><br>C) MORNING STIFFNESS <br/ ><br>D) SWELLING OVER JOINTS <br/ ><br>E) FUNCTIONAL ASSESSMENT: <br/ ><br>F) WALKING TIME <br/ ><br>G) GRIP POWER & PRESSING POWER <br/ ><br>H) RANGE OF MOTIONTimepoint: 90 days study with follow-up of every 30 days
- Secondary Outcome Measures
Name Time Method a. Laboratory Investigations- <br/ ><br>b. Hematological—Hb%, TLC, DLC, ESR <br/ ><br>c. Biochemical—LFT, RFT, Lipid Profile, Blood Sugar. <br/ ><br>d. Anti CCP antibodies(immunopathological marker) <br/ ><br>e. RA factor Quantitative, CRP Quantitative <br/ ><br>f. ASO –titreTimepoint: 90 days study with follow-up of every 30 days